Healthleap, a startup building an AI platform that reads patient records to identify hospitalized patients at risk of undiagnosed illnesses, has raised $38 million in seed and Series A funding, TechCrunch exclusively reported.
The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, the company pivoted from a clinical nutrition tool into a broader platform that mines the unstructured notes in patient charts — poor appetite, recent weight loss, trouble swallowing — for signs of conditions like malnutrition or delirium that are not often identified early enough.
The platform is currently deployed in more than 50 hospitals, where it screens patients for malnutrition and delirium, and the startup has built programs to flag aspiration pneumonia, pressure ulcers and congestive heart failure readmission risk that are undergoing further clinical validation.
The raise adds to a busy week for health AI, as investors keep pouring capital into clinical tools that promise to catch what busy wards miss.
